Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Apella
AddedFeb 15, 2024
UpdatedJun 18, 2026
Apella

Apella

Series A

Apella Technology: An AI startup revolutionizing surgery with modern engineering solutions.

HQ
San Francisco, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize surgery through advanced engineering, Apella Technology leverages artificial intelligence to enhance surgical procedures. The company aims to digitize operating rooms, providing cutting-edge solutions that improve surgical outcomes and efficiency. Apella's core offerings focus on AI-driven tools designed to assist surgeons and medical staff, making surgeries safer and more effective. Their market focus includes hospitals and surgical centers looking to integrate modern technology into their operating rooms.

Notable figures associated with Apella include Kevin Sowers, who has joined the Board of Directors, and Jordan Tuttle, a key advocate for the company's innovative approach. Apella has achieved significant milestones, including a collaboration with Houston Methodist to expand their technology across all operating rooms and securing substantial Series A funding. The impact of Apella's technology is profound, marking a new era of innovation in surgery by enhancing precision, reducing errors, and ultimately improving patient outcomes.

Apella - Similar Companies

surgical.ai logo

surgical.ai

surgical.ai

CaseCTRL logo

CaseCTRL

casectrl.com

Enhatch logo

Enhatch

enhatch.com

Sanus Solutions logo

Sanus Solutions

sanussolutions.com

ORtelligence logo

ORtelligence

ortelligence.com

Kaliber Labs logo

Kaliber Labs

Vision Surgery AI logo

Vision Surgery AI

vision-surgery.ai

Apical Technology logo

Apical Technology

apical.ai

nSight Surgical logo

nSight Surgical

nsightsurgical.ai

Innovo Surgical logo

Innovo Surgical

innovosurgical.com

OrthoGrid Systems logo

OrthoGrid Systems

orthogrid.com

Copient Health logo

Copient Health

copienthealth.com

Asensus Surgical logo

Asensus Surgical

asensus.com

Ampaworks logo

Ampaworks

ampaworks.com

dopl technologies logo

dopl technologies

Apella - Quick Facts

Who are Apella's competitors?

Companies similar to Apella include surgical.ai, CaseCTRL, Enhatch and Sanus Solutions.

When was Apella founded?

Apella was founded in 2019.

Where is Apella's headquarters located?

Apella's headquarters is located in San Francisco, CA, US.

When was Apella's last funding round?

Apella's most recent funding round was for $21M (USD) in December 2021.

How much has Apella raised to-date?

As of Dec 20, 2021, Apella has raised a total of $24M (USD).

How many employees does Apella have?

Apella has 71 employees as of Feb 4, 2024.

Apella - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Surgical Tools
Tags
  • AI Operations
  • Data Information
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software